[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100603070":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":12,"locations":18,"responsibleParty":41,"collaborators":10,"id":43,"slug":44,"hasResults":45,"nctId":46,"briefTitle":47,"officialTitle":47,"acronym":10,"eligibilityCriteria":48,"healthyVolunteers":45,"sex":49,"minAge":50,"maxAge":10,"enrollmentInfo":51,"targetDuration":54,"studyType":55,"phases":10,"briefSummary":56,"conditions":57,"keywords":59,"overallStatus":21,"whyStopped":10,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":73},{"fullName":5,"class":6},"Pontificia Universidad Catolica de Chile","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Patients who have undergone conservative breast cancer surgery",null,"This group will undergo an analysis of gases emitted by cauterization. This intervention will not modify the duration of the surgery, nor will it alter the patient's treatment and prognosis. The gases will be analyzed through the detection device, which will not have direct contact with the patient and will not influence the surgical outcomes of the resection surgery. The patient will be followed for 2 years through their clinical care records in the UC Christus health network, looking for the occurrence of disease recurrence.",[13],{"name":14,"role":15,"phone":16,"phoneExt":10,"email":17},"Maximiliano L Mariné","CONTACT","+56952084996","maxmarine@uc.cl",[19,33],{"facility":20,"status":21,"city":22,"state":23,"zip":24,"country":25,"countryCode":26,"cosmosGeoPoint":27,"geoPoint":32,"contacts":10},"Hospital Clínico UC CHRISTUS","RECRUITING","Santiago","Santiago Centro","8320000","Chile","CL",{"type":28,"coordinates":29},"Point",[30,31],-70.64827,-33.45694,{"lat":31,"lon":30},{"facility":34,"status":35,"city":22,"state":36,"zip":37,"country":25,"countryCode":26,"cosmosGeoPoint":38,"geoPoint":40,"contacts":10},"Facultad de medicina UC","ACTIVE_NOT_RECRUITING","Santiago Metropolitan","8330191",{"type":28,"coordinates":39},[30,31],{"lat":31,"lon":30},{"type":42,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100603070","intraoperative-detection-of-breast-cancer-by-electrosurgical-gas-analysis-and-artificial-intelligence-100603070",false,"NCT07131735","Intraoperative Detection of Breast Cancer by Electrosurgical Gas Analysis and Artificial Intelligence","Inclusion Criteria:\n\n* Histologically confirmed diagnosis of malignant breast cancer\n* Scheduled for BCS at the Hospital UC\n* Able and willing to provide informed consent\n\nExclusion Criteria:\n\n* Pregnant or lactating women\n* Patients with known hypersensitivity or allergy to any component of the BCGC device\n* Participation in another interventional clinical trial within 30 days prior to enrolment","FEMALE","18 Years",{"count":52,"type":53},30,"ESTIMATED","3 Years","OBSERVATIONAL","The aim of this clinical trial is to assess the feasibility of training a device capable of distinguishing various gases emitted by tissues cauterized by an electrosurgical unit during a breast cancer resection surgery. The patients to be enrolled will be women over 18 years old diagnosed with breast cancer who are indicated for conservative breast cancer resection surgery as treatment.\n\nThe main questions to be answered are:\n\nThe specificity and sensitivity of the device in detecting margins compromised with tumor cells in resection surgeries.\n\nEvaluate the applicability of the device in breast cancer surgeries for real-time detection of margins.\n\nEvaluate the differences in the pattern of gases emitted in tumor cells vs normal cells.\n\nBy consenting, the study patients will allow the investigative team to access the clinical record, results of images, post-surgical biopsies, recording of the surgery while preserving the patient's anonymity, and the installation of the gas detection device. This device does not alter the flow of the surgery and does not add additional risk to it.",[58],"Breast Cancer",[58,60,61,62,63],"odors and cancer","breast surgery","intraoperative margin assistant","artificial intelligence","2025-08-12",{"date":66,"type":67},"2025-08-20","ACTUAL",{"date":69,"type":67},"2023-12-18",{"date":71,"type":53},"2025-09-18",{"name":5,"class":6},2]